首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   137852篇
  免费   10052篇
  国内免费   3614篇
耳鼻咽喉   1071篇
儿科学   2625篇
妇产科学   1910篇
基础医学   8478篇
口腔科学   3016篇
临床医学   16362篇
内科学   20241篇
皮肤病学   2428篇
神经病学   7168篇
特种医学   5118篇
外国民族医学   40篇
外科学   13451篇
综合类   19987篇
一般理论   2篇
预防医学   5798篇
眼科学   2249篇
药学   12732篇
  76篇
中国医学   11602篇
肿瘤学   17164篇
  2024年   45篇
  2023年   2326篇
  2022年   3351篇
  2021年   5237篇
  2020年   5549篇
  2019年   4655篇
  2018年   4383篇
  2017年   5188篇
  2016年   5292篇
  2015年   5122篇
  2014年   9821篇
  2013年   12427篇
  2012年   8292篇
  2011年   8994篇
  2010年   7340篇
  2009年   6801篇
  2008年   6732篇
  2007年   7061篇
  2006年   6270篇
  2005年   5617篇
  2004年   4554篇
  2003年   4131篇
  2002年   3368篇
  2001年   2926篇
  2000年   2429篇
  1999年   1901篇
  1998年   1537篇
  1997年   1315篇
  1996年   1102篇
  1995年   1120篇
  1994年   881篇
  1993年   700篇
  1992年   610篇
  1991年   576篇
  1990年   458篇
  1989年   406篇
  1988年   410篇
  1987年   338篇
  1986年   285篇
  1985年   333篇
  1984年   297篇
  1983年   211篇
  1982年   217篇
  1981年   218篇
  1980年   176篇
  1979年   156篇
  1978年   98篇
  1977年   61篇
  1976年   62篇
  1975年   41篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
ObjectivesThe aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency.BackgroundAngiography is limited in assessing the underlying pathophysiological mechanisms of the culprit lesion.MethodsEROSION III (Optical Coherence Tomography–Guided Reperfusion in ST-Segment Elevation Myocardial Infarction With Early Infarct Artery Patency) is an open-label, prospective, multicenter, randomized, controlled study approved by the ethics committees of participating centers. Patients with STEMI who had angiographic diameter stenosis ≤ 70% and TIMI (Thrombolysis In Myocardial Infarction) flow grade 3 at presentation or after antegrade blood flow restoration were recruited and randomized to either OCT guidance or angiographic guidance. The primary efficacy endpoint was the rate of stent implantation.ResultsAmong 246 randomized patients, 226 (91.9%) constituted the per protocol set (112 with OCT guidance and 114 with angiographic guidance). The median diameter stenosis was 54.0% (IQR: 48.0%-61.0%) in the OCT guidance group and 53.5% (IQR: 43.8%-64.0%) in the angiographic guidance group (P = 0.57) before randomization. Stent implantation was performed in 49 of 112 patients (43.8%) in the OCT group and 67 of 114 patients (58.8%) in the angiographic group (P = 0.024), demonstrating a 15% reduction in stent implantation with OCT guidance. In patients treated with stent implantation, OCT guidance was associated with a favorable result with lower residual angiographic diameter stenosis (8.7% ± 3.7% vs 11.8% ± 4.6% in the angiographic guidance group; P < 0.001). Two patients (1 cardiac death, 1 stable angina) met the primary safety endpoint in the OCT guidance group, as did 3 patients (3 cardiac deaths) in the angiographic guidance group (1.8% vs 2.6%; P = 0.67). Reinfarction was not observed in either group. At 1 year, the rates of predefined cardiocerebrovascular events were comparable between the groups (11.6% after OCT guidance vs 9.6% after angiographic guidance; P = 0.66).ConclusionsIn patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary percutaneous coronary intervention. These favorable results indicate the value of OCT imaging in optimizing the reperfusion strategy of patients with STEMI. (EROSION III: OCT- vs Angio-Based Reperfusion Strategy for STEMI; NCT03571269)  相似文献   
2.
目的 观察埃克替尼联合抗血管药物一线治疗表皮生长因子受体(epidermal growth factor receptor,EGFR)突变晚期肺腺癌的治疗效果和不良反应。方法 选取首都医科大学宣武医院胸科2018年6月1日至2019年12月31日期间,37例EGFR突变晚期肺腺癌的患者。采用埃克替尼(125 mg/次,3 次/d)联合贝伐单抗(7.5 mg/kg,1次/3周);或埃克替尼(125 mg/次,3 次/d)联合安罗替尼(10~12 mg 1次/d,第1~14天),均21 d为1个周期,至疾病进展或出现严重的不良反应后终止。中位随访时间14.5(9.2~30.8)个月。结果 本组患者中,62.2%(23/37)达到部分缓解,37.8% (14/37) 达到疾病稳定。客观有效率为62.2%(23/37),疾病控制率为100%(37/37)。中位疾病无进展时间为17.9个月(95% CI:10.292~25.508)个月。1年生存率为83.8%,18个月生存率为81.1%。多因素Cox回归分析结果显示,肝转移和脑转移对患者的PFS有明显影响(P<0.05)。最常见不良反应为皮疹(43.2%, 16/37)和腹泻(21.6%, 8/37)。结论 埃克替尼联合抗血管药物是一种有效且安全的一线治疗EGFR突变晚期肺腺癌的方案。  相似文献   
3.
目的 探讨树突状细胞-细胞因子诱导的杀伤细胞(DC-CIK)联合表皮生长因子受体酪氨酸激酶抑制剂(EGRF-TKI)治疗老年晚期表皮生长因子受体(EGFR)突变肺癌的临床疗效。 方法 将70例Ⅳ期EGFR突变肺癌患者分为治疗组和对照组。治疗组35例,给予DC-CIK细胞治疗联合吉非替尼或厄洛替尼靶向治疗;对照组35例,给予吉非替尼或厄洛替尼靶向治疗。 结果 治疗组的疾病控制率(DCR)为88.6%,高于对照组的68.6%(P=0.041),治疗组生活质量评分改善率为71.4%,高于对照组的45.7%(P=0.029),差异均有统计学意义。治疗组和对照组的1年、2年和3年总生存(OS)率分别为62.9% vs 57.1%、37.1% vs 31.4%和8.6% vs 2.9%,两组比较差异无统计学意义(P=0.217)。治疗组和对照组的1年、2年和3年无进展生存(PFS)率分别为57.1% vs 31.4%、20.0% vs 5.7%和2.9% vs 0%,两组差异有统计学意义(P=0.005)。多因素分析显示,腺癌(HR=0.178,95%CI:0.061~0.523)及高分化(HR=0.058,95%CI:0.015~0.228)患者OS更长,腺癌(HR=0.271,95%CI:0.094~0.777)及高分化(HR=0.089,95%CI:0.029~0.272)患者PFS也更长。治疗组和对照组不良反应发生率差异无统计学意义(P>0.05)。 结论 DC-CIK细胞联合EGRF-TKI可以提高晚期老年EGFR突变肺癌患者的疾病控制率和生活质量,延长患者的PFS。  相似文献   
4.
目的观察小儿推拿联合耳穴贴压治疗小儿变应性鼻炎(AR)肺虚感寒证的临床疗效。方法选取2019年1月至2020年6月在丽水市人民医院儿科治疗的AR肺虚感寒证患儿70例,采用随机数字表法分为治疗组和对照组,各35例。对照组给予常规西药治疗,治疗组给予小儿推拿联合耳穴贴压法治疗,2组均以1个月为1个疗程,1个疗程后统计临床疗效、中医证候评分、治疗前后血清免疫球蛋白E(IgE)和白介素-4(IL-4)水平变化以及复发情况。结果治疗组总有效率为91.43%(32/35),显著高于对照组的68.57%(24/35),2组比较,差异有统计学意义(P<0.05)。治疗前,2组中医证候评分比较,差异无统计学意义(P>0.05),具有可比性;治疗后,2组中医证候评分较同组治疗前明显降低(P<0.05),且治疗组降低更显著,差异有统计学意义(P<0.05)。治疗前,2组血清IgE、IL-4水平比较,差异无统计学意义(P>0.05),具有可比性;治疗后,2组IgE、IL-4水平较同组治疗前明显升高(P<0.05),且治疗组升高更显著,差异有统计学意义(P<0.05)。2组随访6个月,治疗组复发率为10.53%(2/19),显著低于对照组的42.86%(6/14),2组比较,差异有统计学意义(P<0.05)。结论小儿推拿联合耳穴贴压治疗小儿AR肺虚感寒证疗效满意,可明显缓解临床症状,提高机体免疫力,降低复发率,值得临床推广应用。  相似文献   
5.
目的观察丁苯酞联合依达拉奉治疗急性脑梗死的临床疗效。方法242例急性脑梗死患者,依据随机数字表法分为研究组与对照组,各121例。对照组采用依达拉奉治疗,研究组采用丁苯酞联合依达拉奉治疗。比较两组治疗前后血液指标、美国国立卫生研究院卒中量表(NIHSS)评分及日常生活能力评定量表评分(Barthel指数)、治疗效果及不良反应发生情况。结果治疗后,两组全血高切粘度、同型半胱氨酸(Hcy)、C反应蛋白(CRP)水平均低于本组治疗前,活化部分凝血活酶时间(APTT)长于本组治疗前,且研究组全血高切粘度、Hcy、CRP水平均低于对照组,APTT长于对照组,差异均有统计学意义(P<0.05)。治疗后,两组NIHSS评分均低于本组治疗前,Barthel指数均高于本组治疗前,且研究组NIHSS评分(10.52±1.96)分低于对照组的(15.17±3.05)分,Barthel指数(85.34±6.76)分高于对照组的(74.82±7.67)分,差异均有统计学意义(P<0.05)。研究组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。两组药物不良反应率比较,差异无统计学意义(P>0.05)。结论急性脑梗死患者运用丁苯酞联合依达拉奉治疗,可减少神经功能缺损,改善患者的生活能力,提升治疗疗效,减少药物不良反应,效果理想。  相似文献   
6.
Semantic instance segmentation is crucial for many medical image analysis applications, including computational pathology and automated radiation therapy. Existing methods for this task can be roughly classified into two categories: (1) proposal-based methods and (2) proposal-free methods. However, in medical images, the irregular shape-variations and crowding instances (e.g., nuclei and cells) make it hard for the proposal-based methods to achieve robust instance localization. On the other hand, ambiguous boundaries caused by the low-contrast nature of medical images (e.g., CT images) challenge the accuracy of the proposal-free methods. To tackle these issues, we propose a proposal-free segmentation network with discriminative deep supervision (DDS), which at the same time allows us to gain the power of the proposal-based method. The DDS module is interleaved with a carefully designed proposal-free segmentation backbone in our network. Consequently, the features learned by the backbone network become more sensitive to instance localization. Also, with the proposed DDS module, robust pixel-wise instance-level cues (especially structural information) are introduced for semantic segmentation. Extensive experiments on three datasets, i.e., a nuclei dataset, a pelvic CT image dataset, and a synthetic dataset, demonstrate the superior performance of the proposed algorithm compared to the previous works.  相似文献   
7.
8.
目的:探讨支持-表达性团体辅助对肺癌病人心理弹性、死亡态度及述情障碍的影响。方法:选取2020年3月—2021年3月收治的84例肺癌病人为研究对象,将2020年3月—2020年8月收治的42例肺癌病人作为对照组,将2020年9月—2021年3月收治的42例肺癌病人作为观察组。对照组给予常规肺癌护理,观察组在基础上给予支持-表达性团体辅助干预。观察并比较两组干预前后心理弹性、死亡态度以及述情障碍情况。结果:干预后观察组病人心理弹性中坚韧、力量、乐观维度评分均高于对照组(P<0.05);观察组病人趋近接受、自然接受、逃离接受评分高于对照组,死亡恐惧、死亡逃避评分低于对照组(P<0.05);观察组病人述情障碍各维度评分低于对照组(P<0.05)。结论:支持-表达性团体辅助可提升肺癌病人心理弹性,提高病人自然接受死亡态度,树立正确的生死观,同时降低病人述情障碍。  相似文献   
9.
BackgroundIn transfusion-related iron overload, haem-derived iron accumulation in monocytes/macrophages is the initial event. When iron loading exceeds the ferritin storage capacity, iron is released into the plasma. When iron loading exceeds transferrin binding capacity, labile, non-transferrin-bound iron (NTBI) appears and causes organ injury. Haemin-induced cell death has already been investigated; however, whether NTBI induces cell death in monocytes/macrophages remains unclear.Material and MethodsHuman monocytic THP-1 cells were treated with haemin or NTBI, particularly ferric ammonium citrate (FAC) or ferrous ammonium sulfate (FAS). The intracellular labile iron pool (LIP) was measured using an iron-sensitive fluorescent probe. Ferritin expression was measured by western blotting.ResultsLIP was elevated after haemin treatment but not after FAC or FAS treatment. Reactive oxygen species (ROS) generation and cell death induction were remarkable after haemin treatment but not after FAC or FAS treatment. Ferritin expression was not different between the FAC and haemin treatments. The combination of an iron chelator and a ferroptosis inhibitor significantly augmented the suppression of haemin cytotoxicity (p = 0.011).DiscussionThe difference in LIP suggests the different iron traffic mechanisms for haem-derived iron and NTBI. The Combination of iron chelators and antioxidants is beneficial for iron overload therapy.  相似文献   
10.
《Australian critical care》2022,35(4):362-368
BackgroundThere are limited published data on physical activity of survivors of critical illness engaged in rehabilitation in hospital, despite it plausibly influencing outcome.ObjectiveThe aims of this study were to measure physical activity of patients with critical illness engaged in rehabilitation in the intensive care unit (ICU) and on the acute ward and report discharge destination, muscle strength, and functional outcomes.MethodsThis was a single-centre, prospective observational study. Adults with critical illness, who received ≥48 h of invasive mechanical ventilation, and who were awake and able to participate in rehabilitation were eligible. To record physical activity, participants wore BodyMedia SenseWear Armbands (BodyMedia Incorporated, USA), during daylight hours, from enrolment until hospital discharge or day 14 of ward stay (whichever occurred first). The primary outcome was time (minutes) spent performing physical activity at an intensity of greater than 1.5 Metabolic Equivalent Tasks. Secondary outcomes included discharge destination, muscle strength, and physical function.ResultsWe collected 807 days of physical activity data (363 days ICU, 424 days ward) from 59 participants. Mean (standard deviation) duration of daily physical activity increased from the ICU, 17.8 (22.8) minutes, to the ward, 52.8 (51.2) minutes (mean difference [95% confidence interval] = 35 [23.8–46.1] minutes, P < .001). High levels of activity in the ICU were associated with higher levels of activity on the ward (r = .728), n = 48, P < .001.ConclusionsPatients recovering from critical illness spend less than 5% of the day being physically active throughout hospital admission, even when receiving rehabilitation. Physical activity increased after discharge from intensive care, but had no relationship with discharge destination. Only the absence of ICU-acquired weakness on awakening was associated with discharge directly home from the acute hospital. Future studies could target early identification of ICU-acquired weakness and the preservation of muscle strength to improve discharge outcomes.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号